Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis
Clinical trial NCT00925002 · COMPLETED
Trial details
- NCT number
- NCT00925002
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-05
- Primary completion
- 2020-07-08
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.